Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium, Valproic Acid, and Carbamazepine in Bipolar Disorder Mixed Episodes
NCT02870283Phase 4Completed
- Sponsor
- Universidade Federal do Rio Grande do Sul
- Start
- May 2010
- Primary completion
- Nov 2014
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 4 trial of lithium, valproic acid, carbamazepine in bipolar disorder (BD), sponsored by Universidade Federal do Rio Grande do Sul. Started May 2010; status: completed.
02
Drugs
lithiumvalproic acidcarbamazepine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02870283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02870283.